Cooperative Agreement NU51CK000383
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$2.7M
Funding Federal Agency
National Center for Emerging and Zoonotic Infectious Diseases
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.323
Assistance Type
Cooperative Agreement
Place of Performance
Arizona, USA
Similar Awards
This federal Cooperative Agreement award, valued at $827,904.00 and effective August 1, 2024, was issued by the National Center for Emerging and Zoonotic Infectious Diseases, a component of the Centers for Disease Control and Prevention (CDC). It is part of the CDC's Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), which aims to strengthen public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases. The...
This $1,339,555 Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Response program (CFDA 93.354), supports the Maricopa County Department of Public Health in Arizona to rapidly mobilize, surge, and respond to public health emergencies. The key objectives are to: 1) strengthen incident management; 2) strengthen jurisdictional recovery; 3) strengthen biosurveillance; 4) strengthen information management; 5) strengthen...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) provides $1,050,000.00 to the University of Arizona to conduct community-based participatory research to enhance vaccine uptake across the lifespan through innovative points of access and altering norms in border and rural regions. The award period runs from September 30, 2024 to September 29, 2029. The ELC...
The New Mexico Department of Health was awarded a $3,393,370 Cooperative Agreement under the Centers for Disease Control and Prevention's (CDC) Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award has a performance period from August 1, 2024 to July 31, 2029. The funding will support a wide range of public health activities in New Mexico, including enhancing epidemiological surveillance, laboratory testing capabilities, health information systems,...
This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) provides $1,072,379 to the Colorado Department of Public Health and Environment (CDPHE) to enhance their capacity for detecting, responding to, preventing, and controlling infectious diseases. The award will fund a variety of activities over the 5-year period from August 1, 2024 to July 31, 2029,...
The District of Columbia Department of Health (DC Health) was awarded a $2,199,789 Cooperative Agreement from the Centers for Disease Control and Prevention's (CDC) Emerging Infections Programs (CFDA 93.317) to support epidemiology and laboratory capacity for prevention and control of emerging infectious diseases in the District. The award period is from August 1, 2024 to July 31, 2029. This funding will allow DC Health and its public health laboratory partner to enhance their surveillance, data...
The Arizona Department of Health Services (ADHS) was awarded a $52,028,316 five-year Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Preparedness (PHEP) program (CFDA 93.421). The grant supports efforts to enhance public health infrastructure and service delivery across Arizona, with a focus on building capacity in areas such as public health emergency preparedness, disease surveillance, workforce development, and data...
This federal Cooperative Agreement award, ID NU51CK000343, was provided by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The $1,657,860 award to the Massachusetts Department of Public Health (MDPH) will support a 5-year project from Aug 1, 2024 to Jul 31, 2029 to enhance the state's public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases....
The Centers for Disease Control and Prevention (CDC) awarded a five-year $1,658,544 Cooperative Agreement under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) to the State of North Carolina Department of Health & Human Services. The award aims to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases in North Carolina. Key activities include strengthening epidemiological surveillance,...
This federal Cooperative Agreement award of $4,611,703.00 from the National Center for Emerging and Zoonotic Infectious Diseases, part of the Centers for Disease Control and Prevention (CDC), supports the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award aims to strengthen public health systems and services through national partnerships to improve and protect the nation's health. Specifically, the funding will allow the Association of State and...